Skip to main content
Protein EngineeringScientific Breakthrough· 3 min read· in Science

DNA Used as Programmable Scaffold to Assemble Protein Crystals, Revolutionizing Drug Design

Researchers have successfully repurposed flexible DNA strands as a programmable molecular glue to assemble proteins into highly ordered crystals. The breakthrough bypasses the decades-old bottleneck of trial-and-error protein crystallization, accelerating structural biology and the development of novel biomaterials.

By Ishani Patel

Share this story

Listen

For decades, determining the three-dimensional structure of a protein has been one of biology's most frustrating bottlenecks.[2]

Now, a team of chemists at Northwestern University has published a breakthrough in Science Advances that replaces this unpredictable trial-and-error process with intentional, programmable design.[1][2]

By repurposing flexible strands of DNA as a "molecular glue," the researchers successfully directed proteins to self-assemble into highly ordered, diffraction-quality crystals.[3]

The evidence supporting this claim is substantial: the team grew more than 1,000 protein crystals and determined the atomic structures of 28 distinct protein-DNA designs.[2][4]

To understand the magnitude of this shift, one must look at the traditional method of X-ray crystallography.[2]

Scientists typically coax billions of identical proteins to form a crystal, shine X-rays through it, and use the resulting diffraction patterns to map the atomic structure.[2]

How DNA base-pairing acts as a programmable scaffold to assemble protein crystals.

However, proteins are notoriously finicky; they vary wildly in their chemistry and often refuse to crystallize, forcing researchers to rely on brute-force experimental screening.[5]

The Northwestern team, led by nanotechnology pioneer Chad Mirkin, bypassed this by attaching short, single-stranded DNA sequences to the surface of proteins.[2][3]

DNA possesses highly predictable binding rules—adenine always pairs with thymine, and cytosine pairs with guanine.[4]

When these modified proteins are mixed, the complementary DNA strands seek each other out and spontaneously snap together, pulling the attached proteins into a predetermined, highly ordered lattice.[1]

"These numbers show that we didn't just get lucky," Mirkin noted, emphasizing that the direct visualization of DNA double helices linking neighboring proteins proves the assembly is directed by design, not chance.[2]

The Northwestern team validated their method by growing over 1,000 crystals and solving 28 distinct structures.

A particularly striking finding from the study overturns a long-held assumption in materials science and crystallography.[2][3]

Historically, scientists believed that highly ordered crystals required rigid building blocks to maintain their strict geometric symmetry.

The DNA-protein crystals, however, are unusually soft and flexible, yet they still achieve the atomic-level order required to diffract X-rays cleanly.[2][4]

This flexibility is a feature, not a bug. By altering the length, sequence, and placement of the DNA strands, researchers can tune the architecture and mechanical properties of the resulting crystal.[3]

This modularity extends the utility of the breakthrough far beyond structural biology and the immediate needs of X-ray crystallography.[5][6]

The breakthrough promises to drastically reduce the time researchers spend trying to crystallize proteins for structural analysis.

If proteins can be treated as customizable building blocks, scientists can engineer entirely new classes of programmable biomaterials.[4]

Potential applications include advanced biosensors, targeted drug delivery systems, bioelectronic devices, and soft robotic materials that leverage the natural catalytic functions of proteins.[2]

While the primary evidence is robust for the proteins tested, transparent uncertainty remains regarding the universal applicability of the method across all biological molecules.[1]

It is not yet fully established how well this DNA-scaffolding approach will work for the most notoriously difficult targets, such as large, hydrophobic membrane proteins, which are highly sought after for pharmaceutical development.[1][5]

Where opinion splits

Structural Biologists

Viewing the breakthrough as a solution to a decades-old experimental bottleneck.

For structural biologists, the primary value of this research lies in its ability to bypass the unpredictable nature of protein crystallization. Historically, researchers have spent months or years tweaking solvent conditions, pH levels, and temperatures in the hopes of coaxing a stubborn protein into a lattice. By decoupling the crystallization process from the innate chemical properties of the target protein, this DNA-scaffolding method transforms a game of chance into an exercise in rational engineering, promising a higher throughput for determining unknown structures.

Materials Scientists

Focusing on the creation of novel, flexible biomaterials with tunable properties.

Materials scientists emphasize the physical properties of the resulting crystals rather than just their utility for X-ray diffraction. The discovery that highly ordered lattices can be constructed from flexible building blocks challenges traditional crystallographic assumptions. Because the length and sequence of the DNA struts can be precisely modified, researchers can now engineer soft, porous materials with specific mechanical and chemical characteristics, paving the way for advanced biosensors, bioelectronic devices, and smart drug-delivery vehicles.

Pharmaceutical Developers

Prioritizing the acceleration of structure-based drug design and target identification.

In the pharmaceutical industry, time is the most critical metric. The ability to rapidly and reliably determine the atomic structure of disease-related proteins directly translates to faster drug discovery. Pharmaceutical developers view this programmable assembly technique as a tool to quickly map the binding pockets of novel therapeutic targets, allowing computational chemists to design small-molecule drugs that fit those pockets with high precision, ultimately reducing the time and cost required to bring new medications to market.

Key points

  1. Chemists have successfully used flexible DNA strands as a programmable molecular glue to assemble proteins into highly ordered crystals.
  2. The technique replaces the notoriously unpredictable trial-and-error process of protein crystallization with intentional, reproducible design.
  3. Researchers validated the method by growing more than 1,000 protein crystals and determining the atomic structures of 28 distinct designs.
  4. The resulting crystals are unusually soft and flexible, overturning the assumption that highly ordered lattices require rigid building blocks.

Unanswered questions

  • Whether this DNA-scaffolding technique will be equally effective for large, complex membrane proteins, which are notoriously difficult to crystallize but crucial for drug discovery.
  • The long-term stability of these highly flexible, DNA-linked protein crystals outside of strictly controlled laboratory environments.
  • How easily this process can be scaled up for commercial or industrial manufacturing of programmable biomaterials.

How we got here

  1. 1980

    Structural DNA nanotechnology is invented, introducing the vision that DNA scaffolds could one day organize proteins into self-assembled crystals.

  2. 1996

    Researchers first demonstrate that complementary DNA strands can be used to assemble inorganic gold nanoparticles into ordered structures.

  3. July 2026

    Northwestern University chemists publish a breakthrough in Science Advances, successfully using flexible DNA to direct proteins into diffraction-quality crystals.

Structural Biologists 40%Materials Scientists 35%Pharmaceutical Developers 25%
Structural Biologists
Viewing the breakthrough as a solution to a decades-old experimental bottleneck.
Materials Scientists
Focusing on the creation of novel, flexible biomaterials with tunable properties.
Pharmaceutical Developers
Prioritizing the acceleration of structure-based drug design and target identification.

Perspectives this story doesn't cover

  • Computational Biologists

Sources

Source coverage

6 outlets

3 viewpoints surfaced

Structural Biologists 40%Materials Scientists 35%Pharmaceutical Developers 25%
  1. [1]Science AdvancesStructural Biologists

    DNA-directed assembly of proteins into highly ordered flexible crystals

    Read on Science Advances →
  2. [2]Northwestern UniversityMaterials Scientists

    Flexible DNA transforms protein crystallization

    Read on Northwestern University →
  3. [3]ScienmagPharmaceutical Developers

    Flexible DNA transforms protein crystallization

    Read on Scienmag →
  4. [4]BioengineerPharmaceutical Developers

    Flexible DNA transforms protein crystallization

    Read on Bioengineer →
  5. [5]bioRxivStructural Biologists

    Engineered protein–DNA co-crystals combining modular DNA programmability with robust protein-lattice diffraction

    Read on bioRxiv →
  6. [6]American Chemical SocietyMaterials Scientists

    Isoreticular Cocrystal Design Offers a Route to a Programmable Scaffold for DNA-Binding Molecules

    Read on American Chemical Society →
Listen

Comments

Stay informed

Every angle. Every day.

Get Science stories with full source coverage and perspective breakdowns, free every day.